169 related articles for article (PubMed ID: 26073278)
1. The preclinical data forum network: A new ECNP initiative to improve data quality and robustness for (preclinical) neuroscience.
Steckler T; Brose K; Haas M; Kas MJ; Koustova E; Bespalov A;
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1803-7. PubMed ID: 26073278
[TBL] [Abstract][Full Text] [Related]
2. European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP).
Fusar-Poli P; Bauer M; Borgwardt S; Bechdolf A; Correll CU; Do KQ; Domschke K; Galderisi S; Kessing LV; Koutsouleris N; Krebs MO; Lennox B; McGuire P; Meyer-Lindenberg A; Millan MJ; Nieman D; Pfennig A; Sand M; Whenert A; van Amelsvoort T; Arango C
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1301-1311. PubMed ID: 31606303
[TBL] [Abstract][Full Text] [Related]
3. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
4. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
[TBL] [Abstract][Full Text] [Related]
5. Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation.
Lefer DJ; Bolli R
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):332-9. PubMed ID: 21821536
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility in science: improving the standard for basic and preclinical research.
Begley CG; Ioannidis JP
Circ Res; 2015 Jan; 116(1):116-26. PubMed ID: 25552691
[TBL] [Abstract][Full Text] [Related]
7. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
8. The future of preclinical animal models in pharmaceutical discovery and development: a need to bring in cerebro to the in vivo discussions.
Everitt JI
Toxicol Pathol; 2015 Jan; 43(1):70-7. PubMed ID: 25351920
[TBL] [Abstract][Full Text] [Related]
9. Authors' Submission Toolkit: a practical guide to getting your research published.
Chipperfield L; Citrome L; Clark J; David FS; Enck R; Evangelista M; Gonzalez J; Groves T; Magrann J; Mansi B; Miller C; Mooney LA; Murphy A; Shelton J; Walson PD; Weigel A
Curr Med Res Opin; 2010 Aug; 26(8):1967-82. PubMed ID: 20569069
[TBL] [Abstract][Full Text] [Related]
10. Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science?
Bespalov A; Steckler T
J Neurosci Methods; 2018 Apr; 300():4-9. PubMed ID: 29107620
[TBL] [Abstract][Full Text] [Related]
11. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
12. Brainhack: a collaborative workshop for the open neuroscience community.
Cameron Craddock R; S Margulies D; Bellec P; Nolan Nichols B; Alcauter S; A Barrios F; Burnod Y; J Cannistraci C; Cohen-Adad J; De Leener B; Dery S; Downar J; Dunlop K; R Franco A; Seligman Froehlich C; J Gerber A; S Ghosh S; J Grabowski T; Hill S; Sólon Heinsfeld A; Matthew Hutchison R; Kundu P; R Laird A; Liew SL; J Lurie D; G McLaren D; Meneguzzi F; Mennes M; Mesmoudi S; O'Connor D; H Pasaye E; Peltier S; Poline JB; Prasad G; Fraga Pereira R; Quirion PO; Rokem A; S Saad Z; Shi Y; C Strother S; Toro R; Q Uddin L; D Van Horn J; W Van Meter J; C Welsh R; Xu T
Gigascience; 2016; 5():16. PubMed ID: 27042293
[TBL] [Abstract][Full Text] [Related]
13. Irreproducibility in Preclinical Biomedical Research: Perceptions, Uncertainties, and Knowledge Gaps.
Jarvis MF; Williams M
Trends Pharmacol Sci; 2016 Apr; 37(4):290-302. PubMed ID: 26776451
[TBL] [Abstract][Full Text] [Related]
14. New approaches in psychiatric drug development.
van der Doef TF; Zaragoza Domingo S; Jacobs GE; Drevets WC; Marston HM; Nathan PJ; Tome MB; Tamminga CA; van Gerven JMA; Kas MJH
Eur Neuropsychopharmacol; 2018 Sep; 28(9):983-993. PubMed ID: 30056086
[TBL] [Abstract][Full Text] [Related]
15. Guidelines and Initiatives for Good Research Practice.
Kabitzke P; Cheng KM; Altevogt B
Handb Exp Pharmacol; 2020; 257():19-34. PubMed ID: 31696346
[TBL] [Abstract][Full Text] [Related]
16. The publication and reproducibility challenges of shared data.
Poldrack RA; Poline JB
Trends Cogn Sci; 2015 Feb; 19(2):59-61. PubMed ID: 25532702
[TBL] [Abstract][Full Text] [Related]
17. Rigor or mortis: best practices for preclinical research in neuroscience.
Steward O; Balice-Gordon R
Neuron; 2014 Nov; 84(3):572-81. PubMed ID: 25442936
[TBL] [Abstract][Full Text] [Related]
18. Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
Liu E; Luthman J; Cedarbaum JM; Schmidt ME; Cole PE; Hendrix J; Carrillo MC; Jones-Davis D; Tarver E; Novak G; De Santi S; Soares HD; Potter WZ; Siemers E; Schwarz AJ
Alzheimers Dement; 2015 Jul; 11(7):840-9. PubMed ID: 26194317
[TBL] [Abstract][Full Text] [Related]
19. Elevating standards for discoveries reported in ACS Chemical Neuroscience: new criteria to enhance reproducibility, experimental transparency, reliability, and the value of negative data.
Lindsley CW
ACS Chem Neurosci; 2014 Oct; 5(10):868-9. PubMed ID: 25315492
[No Abstract] [Full Text] [Related]
20. The extinction of drugs for clinical research: Can the ECNP medicines chest save them?
Nutt D; Kilpatrick G; Hayes A
Eur Neuropsychopharmacol; 2014 Apr; 24(4):487-90. PubMed ID: 24508534
[No Abstract] [Full Text] [Related]
[Next] [New Search]
